Biosimilars in the Evolving Cancer Care Landscape: Experts Address Current Questions, Controversies, and Impact on Clinical Practice

In this downloadable slideset from the NCCN Biosimilars symposium, Andrew D. Zelenetz, MD, PhD, Jeffrey Crawford, MD, and Lee S. Schwartzberg, MD, FACP, provide expert perspective on integrating biosimilar drugs into your practice to improve the care of patients with cancer.
Format: Microsoft PowerPoint (.ppt)
File Size: 3.38 MB
Released: March 8, 2018

Acknowledgements

Jointly provided by the National Comprehensive Cancer Network and Clinical Care Options, LLC
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
gianola@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

This activity is supported by educational grants from
Amgen
Pfizer Inc.
Sandoz Inc., a Novartis Division

Related Content

Downloadable resource guide for patients who are receiving an FDA-approved BTK inhibitor, acalabrutinib or ibrutinib, from CCO.

Released: June 20, 2019

Overall survival from MONALEESA-7 with ribociclib + ET in pre/perimenopausal women with HR+/HER2- advanced breast cancer as reported by CCO from ASCO 2019

Released: June 11, 2019

Results from Young-PEARL trial of palbociclib plus endocrine therapy vs capecitabine in premenopausal women with HR+ MBC as reported by CCO from ASCO 2019

Released: June 7, 2019

Phase III NALA data on later-line neratinib + capecitabine vs lapatinib + capecitabine in HER2+ MBC, as reported by CCO from ASCO 2019

Released: June 7, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?